Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
*Short Course requires separate registration
Short Course Registration: 8:00AM-5:00PM
This half-day short course will be conducted in two parts. The first part will focus on the basic aspects of the EU Regulation and EU Guidances (including Q&A Documents) that govern the content, placement, use, and management of the Reference Safety Information as used in assessing expectedness of “suspected” serious adverse reactions (SARs) from clinical trials. The second part will focus on the practical aspects of implementing the regulations and guidances, including a review of acceptable and non-acceptable examples of the RSI and examples of regulatory agency inspection findings related to the RSI.
Learning objectives
- Describe the requirements for the use and management of the RSI in clinical trials
- Understand how the requirements for RSI as described in the CTFG Q&A Documents are enforced by regulatory agencies
- Be able to develop compliant RSI processes and documentation
Register for both a morning and afternoon short course and the full conference for $100 off! Registrations must happen at the same time, discounts reflected at checkout.
Contact us
Registration Questions?
Return to
Pharamcovigilance and Risk Management Strategies Conference
Other Preconference Short Courses
Short Course 1: Pharmacovigilance and Risk Management Planning
Short Course 2: Interdisciplinary Safety Evaluation During Product Development
Short Course 4: Introduction to Statistics in Pharmacovigilance